Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
Clinical trial NCT03793478 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03793478
- Sponsor
- Daiichi Sankyo
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-15
- Primary completion
- 2027-05-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.